What does Trails Edge Capital Partners, LP hold? Q4 2025 13F Holdings & Portfolio

AI Analysis · Q4 2025 · Q4 2025

Trails Edge Capital Partners, LP filed its latest 13F-HR for Q4 2025. See the latest holdings and position changes below.

Quarter at a glance — Q4 2025

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q4 2025.

#HoldingValueSharesWeight

ACADIA PHARMACEUTICALS INC

$38M1.4M9.4%

MIND MEDICINE MINDMED INC

$34M2.6M8.5%

VAXCYTE INC

$34M737K8.4%

NURIX THERAPEUTICS INC

$33M1.7M8.2%

LB PHARMACEUTICALS INC

$31M1.4M7.7%

XENON PHARMACEUTICALS INC

$27M597K6.6%

IMMUNOCORE HLDGS PLC

$24M683K5.9%

ARCUS BIOSCIENCES INC

$22M916K5.4%

TYRA BIOSCIENCES INC

$18M700K4.5%

NEUROGENE INC

$16M785K4.0%

Filing history loading…